Cost–Effectiveness of Different Strategies for Stroke Prevention in Patients with Atrial Fibrillation in a Health Resource-Limited Setting

被引：3
|
作者：
Bin Wu
Li Kun
Xiaoyan Liu
Ben He
机构：
[1] Shanghai Jiao Tong University,Clinical Outcomes and Economics Group, Department of pharmacy, Ren Ji Hospital, School of Medicine
[2] Center for ADR Monitoring of Linyi,Department of Cardiology, Ren Ji Hospital, School of Medicine
[3] Shanghai Jiao Tong University,undefined
来源：
Cardiovascular Drugs and Therapy | 2014年 / 28卷
关键词：
Cost-effectiveness; State-transition microsimulation model; Atrial fibrillation; Rivaroxaban; Warfarin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：87 / 98
页数：11
相关论文
共 50 条
  • [1] Cost-Effectiveness of Different Strategies for Stroke Prevention in Patients with Atrial Fibrillation in a Health Resource-Limited Setting
    Wu, Bin
    Kun, Li
    Liu, Xiaoyan
    He, Ben
    CARDIOVASCULAR DRUGS AND THERAPY, 2014, 28 (01) : 87 - 98
  • [2] Cost-effectiveness of prevention and management of diabetic foot ulcer and amputation in a health resource-limited setting
    Wu, Bin
    Wan, Xu
    Ma, Jing
    JOURNAL OF DIABETES, 2018, 10 (04) : 320 - 327
  • [3] Treatment of moderate rheumatoid arthritis with different strategies in a health resource-limited setting: a cost-effectiveness analysis in the era of biosimilar
    Wu, B.
    Song, Y.
    Leng, L.
    Bucala, R.
    Lu, L. J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (01) : 20 - 26
  • [4] Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting
    Morais, Joao
    Aguiar, Carlos
    McLeod, Euan
    Chatzitheofilou, Ismini
    Santos, Isabel Fonseca
    Pereira, Sonia
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2014, 33 (09) : 535 - 544
  • [5] The Cost-Effectiveness of Lifestyle Interventions for Preventing Diabetes in a Health Resource-Limited Setting
    Ma, Jing
    Wan, Xu
    Wu, Bin
    JOURNAL OF DIABETES RESEARCH, 2020, 2020
  • [6] Cost Effectiveness of Rivaroxaban for Stroke Prevention in German Patients with Atrial Fibrillation
    Alexander Mensch
    Stephanie Stock
    Björn Stollenwerk
    Dirk Müller
    PharmacoEconomics, 2015, 33 : 271 - 283
  • [7] Cost Effectiveness of Rivaroxaban for Stroke Prevention in German Patients with Atrial Fibrillation
    Mensch, Alexander
    Stock, Stephanie
    Stollenwerk, Bjoern
    Mueller, Dirk
    PHARMACOECONOMICS, 2015, 33 (03) : 271 - 283
  • [8] The cost effectiveness of antiretroviral treatment strategies in resource-limited settings
    Bishai, David
    Colchero, Arantxa
    Durack, David T.
    AIDS, 2007, 21 (10) : 1333 - 1340
  • [9] COST EFFECTIVENESS OF DABIGATRAN ETEXILATE FOR PREVENTION OF STROKE AND SYSTEMIC EMBOLISM IN NONVALVULAR ATRIAL FIBRILLATION PATIENTS IN THE TURKISH HEALTH CARE SETTING
    Kececioglu, S.
    Ulus, P.
    Cukadar, F.
    VALUE IN HEALTH, 2012, 15 (07) : A373 - A373
  • [10] Comment on "Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting''
    Miguel, Luis Silva
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2015, 34 (11) : 705 - 706
12345